These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28074669)

  • 21. LC-MS/TOF and UHPLC-MS/MS study of in vivo fate of rifamycin isonicotinyl hydrazone formed on oral co-administration of rifampicin and isoniazid.
    Prasad B; Singh S
    J Pharm Biomed Anal; 2010 Jul; 52(3):377-83. PubMed ID: 19692195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Automated online liquid chromatographic/mass spectrometric metabolic study for prodrug stability.
    Lai F; Khojasteh-Bakht SC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):225-32. PubMed ID: 15639443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Principles and applications of LC-MS in new drug discovery.
    Korfmacher WA
    Drug Discov Today; 2005 Oct; 10(20):1357-67. PubMed ID: 16253874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent development in high-throughput bioanalytical support for in vitro ADMET profiling.
    Shou WZ; Zhang J
    Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):321-36. PubMed ID: 20163321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An automated liquid chromatography-mass spectrometry process to determine metabolic stability half-life and intrinsic clearance of drug candidates by substrate depletion.
    McNaney CA; Drexler DM; Hnatyshyn SY; Zvyaga TA; Knipe JO; Belcastro JV; Sanders M
    Assay Drug Dev Technol; 2008 Feb; 6(1):121-9. PubMed ID: 18336089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing high-throughput discovery bioanalysis using automated selected reaction monitoring compound optimization, ultra-high-pressure liquid chromatography, and single-step sample preparation workflows.
    Smalley J; Xin B; Olah TV
    Rapid Commun Mass Spectrom; 2009 Nov; 23(21):3457-64. PubMed ID: 19813283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of a rapid and integrated analysis system (RIAS) as a high-throughput processing tool for in vitro ADME samples by liquid chromatography/tandem mass spectrometry.
    Luippold AH; Arnhold T; Jörg W; Krüger B; Süssmuth RD
    J Biomol Screen; 2011 Mar; 16(3):370-7. PubMed ID: 21335598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolites characterization of chamaechromone in vivo and in vitro by using ultra-performance liquid chromatography/Xevo G2 quadrupole time-of-flight tandem mass spectrometry.
    Lou Y; Zheng J; Wang B; Zhang X; Zhang X; Zeng S
    J Ethnopharmacol; 2014; 151(1):242-52. PubMed ID: 24189033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A sensitive LC-MS/MS method to quantify loureirin B in rat plasma with application to preclinical pharmacokinetic studies.
    Li Y; Li Y; Yang Z; Xin N; Deng Y
    J Pharm Biomed Anal; 2009 Dec; 50(5):983-6. PubMed ID: 19660887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. It is time for a paradigm shift in drug discovery bioanalysis: from SRM to HRMS.
    Ramanathan R; Jemal M; Ramagiri S; Xia YQ; Humpreys WG; Olah T; Korfmacher WA
    J Mass Spectrom; 2011 Jun; 46(6):595-601. PubMed ID: 21630388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of drug concentrations in plasma by a highly automated, generic and flexible protein precipitation and liquid chromatography/tandem mass spectrometry method applicable to the drug discovery environment.
    O'Connor D; Clarke DE; Morrison D; Watt AP
    Rapid Commun Mass Spectrom; 2002; 16(11):1065-71. PubMed ID: 11992509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Higher-throughput screening for Caco-2 permeability utilizing a multiple sprayer liquid chromatography/tandem mass spectrometry system.
    Fung EN; Chu I; Li C; Liu T; Soares A; Morrison R; Nomeir AA
    Rapid Commun Mass Spectrom; 2003; 17(18):2147-52. PubMed ID: 12955746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validated bioanalytical method for the quantification of RGB-286638, a novel multi-targeted protein kinase inhibitor, in human plasma and urine by liquid chromatography/tandem triple-quadrupole mass spectrometry.
    de Bruijn P; Moghaddam-Helmantel IM; de Jonge MJ; Meyer T; Lam MH; Verweij J; Wiemer EA; Loos WJ
    J Pharm Biomed Anal; 2009 Dec; 50(5):977-82. PubMed ID: 19628352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current applications of liquid chromatography/mass spectrometry in pharmaceutical discovery after a decade of innovation.
    Ackermann BL; Berna MJ; Eckstein JA; Ott LW; Chaudhary AK
    Annu Rev Anal Chem (Palo Alto Calif); 2008; 1():357-96. PubMed ID: 20636083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of a higher throughput microsomal stability screening assay for profiling drug discovery candidates.
    Di L; Kerns EH; Hong Y; Kleintop TA; McConnell OJ; Huryn DM
    J Biomol Screen; 2003 Aug; 8(4):453-62. PubMed ID: 14567798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Universal LC-MS method for minimized carryover in a discovery bioanalytical setting.
    Williams JS; Donahue SH; Gao H; Brummel CL
    Bioanalysis; 2012 May; 4(9):1025-37. PubMed ID: 22612684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a low volume plasma sample precipitation procedure for liquid chromatography/tandem mass spectrometry assays used for drug discovery applications.
    Xu X; Zhou Q; Korfmacher WA
    Rapid Commun Mass Spectrom; 2005; 19(15):2131-6. PubMed ID: 15988723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of partially porous particle columns for the routine, generic analysis of biological samples for pharmacokinetic studies in drug discovery by reversed-phase ultra-high performance liquid chromatography-tandem mass spectrometry.
    Mallett DN; Ramírez-Molina C
    J Pharm Biomed Anal; 2009 Jan; 49(1):100-7. PubMed ID: 19019615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New developments in automated PrepLCMS extends the robustness and utility of the method for compound library analysis and purification.
    Zeng L; Wang X; Wang T; Kassel DB
    Comb Chem High Throughput Screen; 1998 Jun; 1(2):101-11. PubMed ID: 10500769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid screening for 67 drugs and metabolites in serum or plasma by accurate-mass LC-TOF-MS.
    Marin SJ; Hughes JM; Lawlor BG; Clark CJ; McMillin GA
    J Anal Toxicol; 2012 Sep; 36(7):477-86. PubMed ID: 22802572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.